Access cutting-edge diabetic macular edema treatment through this clinical trial at a research site in Phoenix. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Phoenix location
Access diabetic macular edema specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related diabetic macular edema treatment provided free
Check if you qualify for this diabetic macular edema clinical trial in Phoenix, AZ
No-Cost Study Care
Local to Phoenix
Convenient for AZ residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This study aims to evaluate the ocular and systemic safety, tolerability and efficacy of RO7446603 in participants with diabetic macular edema (DME). The study consists of 2 segments: Phase I (Parts 1-4) and Phase II (Part 5). Phase I investigated the safety of RO7446603 following a single and multiple intravitreal (IVT) doses as monotherapy or co-administered with IVT aflibercept or IVT faricimab (in separate injections). Phase II will investigate the safety, tolerability, pharmacokinetics (PK)
Sponsor: Genentech, Inc.
Yes, this clinical trial (NCT06850922) has an active research site in Phoenix, AZ that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for diabetic macular edema treatment options in Phoenix, AZ, this clinical trial (NCT06850922) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Phoenix research site is actively enrolling participants for this clinical trial. You'll receive care from experienced diabetic macular edema specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all diabetic macular edema clinical trials near you to find additional studies recruiting in your area.
See all essential tremor clinical trials recruiting in Phoenix — not just this study.
Browse Essential Tremor Trials in Phoenix →